Found: 9
Select item for more details and to access through your institution.
Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia.
- Published in:
- Neuropsychopharmacology, 2009, v. 34, n. 8, p. 1885, doi. 10.1038/npp.2009.26
- By:
- Publication type:
- Article
Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized Studies.
- Published in:
- Neuropsychiatric Disease & Treatment, 2020, v. 16, p. 1533, doi. 10.2147/NDT.S221242
- By:
- Publication type:
- Article
Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia.
- Published in:
- Neuropsychiatric Disease & Treatment, 2019, v. 15, p. 1365, doi. 10.2147/NDT.S197225
- By:
- Publication type:
- Article
Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation.
- Published in:
- Neuropsychiatric Disease & Treatment, 2019, v. 15, p. 731, doi. 10.2147/NDT.S194264
- By:
- Publication type:
- Article
Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population
- Published in:
- Neuropsychiatric Disease & Treatment, 2019, v. 15, p. 587, doi. 10.2147/NDT.S189668
- By:
- Publication type:
- Article
Time to onset and time to resolution of extrapyramidal symptoms in patients with exacerbated schizophrenia treated with 3-monthly vs once-monthly paliperidone palmitate.
- Published in:
- Neuropsychiatric Disease & Treatment, 2018, v. 14, p. 2807, doi. 10.2147/NDT.S175364
- By:
- Publication type:
- Article
Efficacy and safety of paliperidone palmitate three-monthly formulation in East Asian patients with schizophrenia: subgroup analysis of a global, randomized, double-blind, Phase III, noninferiority study.
- Published in:
- Neuropsychiatric Disease & Treatment, 2017, v. 13, p. 2193, doi. 10.2147/NDT.S134287
- By:
- Publication type:
- Article
Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study.
- Published in:
- International Journal of Neuropsychopharmacology, 2016, v. 19, n. 7, p. 1, doi. 10.1093/ijnp/pyw018
- By:
- Publication type:
- Article
Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies.
- Published in:
- Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2019, v. 41, n. 6, p. 499, doi. 10.1590/1516-4446-2018-0153
- By:
- Publication type:
- Article